Yield10 Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 04:14 pm EST
Share
Yield10 Bioscience, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 0.111 million compared to USD 0.092 million a year ago. Net loss was USD 3.49 million compared to USD 2.4 million a year ago. Basic loss per share from continuing operations was USD 0.71 compared to USD 0.49 a year ago.
For the nine months, revenue was USD 0.363 million compared to USD 0.462 million a year ago. Net loss was USD 10.26 million compared to USD 8.05 million a year ago. Basic loss per share from continuing operations was USD 2.09 compared to USD 1.72 a year ago.
Yield10 Bioscience, Inc. is an agricultural bioscience company. The Company is using its differentiated trait gene discovery platform, the TraitFactory, to develop improved Camelina varieties for the production of seed products, and to discover high value genetic traits for the agriculture and food industries. The seed products include Camelina oil for use as a low carbon biofuel feedstock, Omega-3 oils for nutrition and PHA Bioplastics for biodegradable zero-waste packaging solutions. It is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low carbon sustainable seed products to address petroleum replacement markets, food and nutrition markets, and animal feed markets. It is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits. The Company's development pipeline falls into three categories: input traits, performance traits and new seed product traits.
YIELD10 BIOSCIENCE, INC. 
